Literature DB >> 17538943

The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer.

Adam Glick1, Andrew Ryscavage, Rolando Perez-Lorenzo, Henry Hennings, Stuart Yuspa, Nadine Darwiche.   

Abstract

Benign tumors that form following chemical initiation and promotion in the mouse skin can be grouped into two classes. The majority of papillomas do not progress to squamous cell carcinoma (SCC), and these are designated as low-risk or terminally benign papillomas. In contrast, a much smaller group forms the true precursor to the SCC, and these have a significantly higher frequency and rate of malignant conversion than the bulk of low-risk papillomas. In standard two-stage carcinogenesis studies both tumor types are present, but grossly indistinguishable. Here we describe properties and potential origins of high-risk papillomas and discuss the relevance of this model for certain human cancers with defined premalignant states.

Entities:  

Mesh:

Year:  2007        PMID: 17538943     DOI: 10.1002/mc.20345

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  10 in total

1.  Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.

Authors:  Rolando Pérez-Lorenzo; Lauren Mordasky Markell; Kelly A Hogan; Stuart H Yuspa; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

2.  T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis.

Authors:  Christophe Cataisson; Rosalba Salcedo; Aleksandra M Michalowski; Mary Klosterman; Shruti Naik; Luowei Li; Michelle J Pan; Amalia Sweet; Jin-Qiu Chen; Laurie G Kostecka; Megan Karwan; Loretta Smith; Ren-Ming Dai; C Andrew Stewart; Lyudmila Lyakh; Wang-Ting Hsieh; Asra Khan; Howard Yang; Maxwell Lee; Giorgio Trinchieri; Stuart H Yuspa
Journal:  Mol Cancer Res       Date:  2019-06-04       Impact factor: 5.852

3.  Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse.

Authors:  Lisbeth K Siddens; Andrew Larkin; Sharon K Krueger; Christopher A Bradfield; Katrina M Waters; Susan C Tilton; Cliff B Pereira; Christiane V Löhr; Volker M Arlt; David H Phillips; David E Williams; William M Baird
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-23       Impact factor: 4.219

4.  Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Authors:  G J Ortiz; Y Li; S M Post; V Pant; S Xiong; C A Larsson; A K El-Naggar; D G Johnson; G Lozano
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

5.  Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression.

Authors:  Lauren Mordasky Markell; Rolando Pérez-Lorenzo; Katelyn E Masiuk; Mary J Kennett; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-09-17       Impact factor: 4.944

6.  Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.

Authors:  K L Decicco-Skinner; E L Trovato; J K Simmons; P K Lepage; J S Wiest
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

7.  Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics.

Authors:  Michael P Waalkes; Jie Liu; Dori R Germolec; Carol S Trempus; Ronald E Cannon; Erik J Tokar; Raymond W Tennant; Jerrold M Ward; Bhalchandra A Diwan
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.

Authors:  E Dodagatta-Marri; D S Meyer; M Q Reeves; R Paniagua; M D To; M Binnewies; M L Broz; H Mori; D Wu; M Adoumie; R Del Rosario; O Li; T Buchmann; B Liang; J Malato; F Arce Vargus; D Sheppard; B C Hann; A Mirza; S A Quezada; M D Rosenblum; M F Krummel; A Balmain; R J Akhurst
Journal:  J Immunother Cancer       Date:  2019-03-04       Impact factor: 13.751

9.  The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models.

Authors:  Adam B Glick
Journal:  J Skin Cancer       Date:  2012-12-26

10.  Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.

Authors:  Wen Fu; Tom McCormick; Xiaoping Qi; Liping Luo; Lingyin Zhou; Xin Li; Bing-Cheng Wang; Heidi E Gibbons; Fadi W Abdul-Karim; George I Gorodeski
Journal:  BMC Cancer       Date:  2009-04-20       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.